Indications 

Feldene Flash is a prescription medicine indicated for a range of conditions necessitating anti-inflammatory and analgesic effects, including: 

• Rheumatoid arthritis 
• Juvenile rheumatoid arthritis 
• Osteoarthritis  
• Ankylosing spondylitis 
• Acute musculoskeletal disorders 
• Acute gout 
• Postoperative and post-traumatic pain 
• Primary dysmenorrhea in patients aged 12 and above 
• Fever and pain relief in cases of acute upper respiratory tract inflammation. 

Classified as a non-steroidal anti-inflammatory drug (NSAID), Feldene Flash functions by suppressing the synthesis of a substance that induces pain, fever, and inflammation in the body. 

Uses and Dosage 

Read the medication guide and patient information leaflet that come with Feldene Flash before starting the treatment or obtaining a prescription refill. If you have concerns or need more information, do not hesitate to contact your pharmacist or doctor. 

Feldene Flash is a fast-dissolving tablet that can be taken with water or placed on the tongue to disperse before swallowing with saliva or water as a suspension. 

The appropriate dosage and duration of treatment with this medication are determined individually, considering the patient’s medical condition, response, and in pediatric cases weight. 

Typically, Feldene Flash is taken once a day with or after a meal as prescribed by the doctor. 

To achieve the best outcomes, adhere to the prescribed instructions when taking Feldene Flash. Do not modify the recommended dose, frequency, or duration of use without consulting your doctor. 

Side Effects 

Feldene Flash is generally well-tolerated, with gastrointestinal symptoms being the most frequently encountered side effects. However, these symptoms typically do not disrupt the treatment process. 

Allergic Reactions 

In rare instances, Feldene Flash may cause a critical allergic response. Promptly seek medical attention should any symptoms of an allergic reaction occur, such as: 

• Skin rash 
• Difficulty in breathing 
• Mouth, face, lips, tongue, or throat swelling 

This list does not cover all side effects of Feldene Flash. Report to your doctor if you observe any other effects. 

Cautions 

Before starting treatment with Feldene Flash, inform your doctor if you have any known hypersensitivities, particularly to piroxicam, aspirin, other NSAIDs, or to any of the inactive ingredients of this fast-dissolving tablet. 

Inform your doctor of your medical history prior to taking Feldene Flash, as this medication is not recommended for: 

• Individuals with a history of gastrointestinal ulcers, bleeding, or perforations 
• Those with active peptic ulcers 
• Patients experiencing asthma, nasal polyps, angioedema, or urticaria symptoms triggered by aspirin or other NSAIDs 
• Use in the context of coronary artery bypass graft (CABG) surgery for peri-operative pain 
• Individuals with severe renal or hepatic failure 
• Patients with severe heart failure 

Disclose to your doctor your medication regimen, including prescription and over-the-counter remedies, vitamins, and herbal supplements, to minimize the risk of drug interaction with Feldene Flash. 

Refrain from taking Feldene Flash along with other systemic non-aspirin NSAIDs, including cyclooxygenase 2 (COX-2) inhibitors, as such concomitant use may elevate the risk of gastrointestinal ulcers and bleeding. 

Feldene Flash contains aspartame; caution should be exercised for individuals with phenylketonuria. 

Feldene Flash may cause new or worsened hypertension, potentially leading to an increased risk of cardiovascular events. Blood pressure should be closely monitored when starting and continuing treatment with this medication. 

Patients experiencing visual issues while taking Feldene Flash are recommended to undergo an ophthalmic assessment. 

Feldene Flash is not recommended during the final trimester of pregnancy. Pregnant women taking this medication in the early stage of pregnancy should undergo close monitoring of their amniotic fluid levels. 

Feldene Flash is not advised for nursing mothers due to the lack of established clinical safety.